“Every new development in cancer research requires a lot of courage and patience”

Dr. Ben J. Lipps, CEO

Dr Ben J. Lipps was appointed to the Board of MagForce AG in September 2013. Between May 1999 and December 2012 he was Chairman of the Board for Fresenius Medical Care. During his time at Fresenius Medical Care, the corporation tripled its turnover from $3.8 billion (USD) to $12.8 billion, while annual net profit increased six-fold to $1.1 billion. Apart from his chairmanship, Dr Lipps was also the Chairman of the Board for Fresenius Medical Care North America until February 2004. From October 1989 to February 2004, he was President, Chief Executive Officer, Chief Operating Officer and Director at Fresenius USA and served in various capacities with the company’s predecessor between 1985 and 1989. Before Dr Lipps joined the Fresenius Group in 1985, he held several research management positions in various companies, including DOW Chemical.

His academic career includes postgraduate and doctoral degrees in chemical engineering at MIT (Massachusetts Institute of Technology).

Prof. Dr. Hoda Tawfik, Chief Medical Officer

Prof Hoda Tawfik joined MagForce AG as Vice President R&D/Medical Affairs in May 2011 and was appointed to the Board in October 2012. She has over 20 years of experience in clinical development and medical affairs in both CRO (contract research organisations) and the pharma/biotech industry. Before joining MagForce, she worked at Medigene AG where she was Head of Clinical Operations and Medical Affairs for nine years.

Hoda Tawfik completed her pharmacy studies at the University of Cairo, and subsequently obtained her PhD in pharmacology and toxicology at the University of Düsseldorf. She then worked in pharmacological research at the universities of Cairo, Heidelberg, and Munich. In addition she held the post of Professor of Pharmacology at the University of Cairo.

Christian von Volkmann, CFO

Christian von Volkmann has been supporting MagForce since May 2012 and as a Member the Board since October 2012. He has more than 15 years of experience in corporate finance/capital market transactions, group structuring, and mergers and acquisitions (M&A). From 2004 to 2010, he held various positions at Jerini AG, most recently as Chief Financial Officer. Amongst his responsibility in this capacity lay the squeeze-out of the minority shareholders and the integration of the Jerini Group into the Shire Group, as well as the spin-off and divestment of business units. From 2010 to 2012, owning CMaP Financial Consulting, Christian von Volkmann advised companies across Europe in disclosure and stock exchange listing requirements as well as in operational management execution.

After his Diploma in business administration at the University of Wuerzburg, he was employed from 1998 to 2004 with Ernst & Young auditors. In 1998 he passed the examination as a Certified Public Accountant in the USA.

Compliant with European Standard